HLA-B57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B57:01-negative subjects

被引：0

作者：

Catherine Butkus Small

David A. Margolis

Mark S. Shaefer

Lisa L. Ross

机构：

[1] Weill Cornell Medical College,

[2] New York Medical College,undefined

[3] ViiV Healthcare,undefined

来源：

BMC Infectious Diseases | / 17卷

关键词：

Abacavir; Lamivudine; Hypersensitivity; HLA-B*57:01; HIV infection;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Prevalence of HLA-B*57:01 allele in HIV-positive and HIV-negative population of eastern India: An epidemiological study
Gautam, Abhilasha
Chakravarty, Jaya
Chourasia, Ankita
Sharma, Saurabh
Sarkar, Tanmoy
Das, Parimal
CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2022, 18
[22] Abacavir adverse reactions related with HLA-B*57:01 haplotype in a large cohort of patients infected with HIV
Quiros-Roldan, Eugenia
Gardini, Giulia
Properzi, Martina
Ferraresi, Alice
Carella, Graziella
Marchi, Alessandro
Malagoli, Alberto
Foca, Emanuele
Castelli, Francesco
PHARMACOGENETICS AND GENOMICS, 2020, 30 (08): : 167 - 174
[23] External quality assessment of patient HLA-B*57:01 testing prior to abacavir prescription
Darke, C.
Corbin, S. A.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2014, 41 (04) : 277 - 280
[24] HLA-B*57 genotyping in a Martinican cohort of HIV-infected patients and Abacavir hypersensitivity:: preliminary results
Paturel, L.
Abel, S.
Nalpas, M.
Cabie, A.
Belon, P.
Bera, O.
TISSUE ANTIGENS, 2008, 71 (04): : 335 - 336
[25] Rapid Near Point-of-Care Assay for HLA-B*57:01 Genotype Associated with Severe Hypersensitivity Reaction to Abacavir
Wallner, Jackson J.
Beck, Ingrid A.
Panpradist, Nuttada
Ruth, Parker S.
Valenzuela-Ponce, Humberto
Soto-Nava, Maribel
Avila-Rios, Santiago
Lutz, Barry R.
Frenkel, Lisa M.
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2021, 37 (12) : 930 - 935
[26] The frequency of HLA-B*57:01 and the risk of abacavir hypersensitivity reactions in the majority population of Costa Rica
Arrieta-Bolanos, Esteban
Madrigal, J. Alejandro
Marsh, Steven G. E.
Shaw, Bronwen E.
Salazar-Sanchez, Lizbeth
HUMAN IMMUNOLOGY, 2014, 75 (11) : 1092 - 1096
[27] THE FREQUENCY OF HLA-B*57:01 AND THE RISK OF ABACAVIR HYPERSENSITIVITY REACTIONS IN THE INDIAN POPULATION: A PILOT STUDY
Chowdhry, Mohit
Makroo, R. N.
Bhadauria, Preeti
Mishra, Manoj
Nag, Nalin
TISSUE ANTIGENS, 2013, 81 (05): : 376 - 376
[28] Effective Screening for the HLA-B*35:05 and HLA-B*57:01 Alleles by Using an Allele-Specific Polymerase Chain Reaction Melting Assay
Matsuda, Yasuhiro
Sano, Hidehiko
Iwaki, Yuichi
INTERNATIONAL CONFERENCE ON BIOLOGICAL, MEDICAL AND CHEMICAL ENGINEERING (BMCE 2013), 2013, : 160 - 168
[29] Pharmacogenetics of abacavir hypersensitivity: A systematic review and meta-analysis of the association with HLA-B*57:01
Sousa-Pinto, Bernardo
Pinto-Ramos, Joao
Correia, Claudia
Goncalves-Costa, Gustavo
Gomes, Lidia
Gil-Mata, Sara
Araujo, Luis
Delgado, Luis
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 136 (04) : 1092 - +
[30] FREQUENCY OF HLA-B*57:01 IN HIV POSITIVE PATIENTS IN THE REPUBLIC OF NORTH MACEDONIA
Dobrevski, Boban
Stevanovic, Milena
Kirijas, Med
Brnjarcevska, Teodora
Milanovski, Gorjan
Petlichkovski, Aleksandar
HLA, 2020, 95 (04) : 374 - 374

← 1 2 3 4 5 →

HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects

HLA-B57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B57:01-negative subjects